| This week's sponsor is Oracle. | | | Cleaner data. Less effort.
Oracle's new integrated, end-to-end clinical data management system can send discrepancies between EDC and labs and other systems, program library elements done in SAS not easily standardized, and track full data lineage. Get the white paper. |
| This week's sponsor is Lenovo Health. | | | Bridging the Patient ID Accuracy Gap
Identity theft is not limited to shady eCommerce websites or restaurant servers. Medical identity theft is mainstream, with over 2 million victims in the last year alone. Get the stats you need to start down the path to a more secure infrastructure, today.
Download the Infographic. |
Top Stories Wednesday, October 12, 2016 AstraZeneca has halted a Phase IIa trial of the severe asthma drug it licensed from Synairgen. The Big Pharma took action after an interim analysis raised doubts about whether the study could deliver meaningful data against its primary endpoint, throwing the future of the program into question and wiping 40% off Synairgen’s share price. Wednesday, October 12, 2016 German Merck has inked another combo trial deal, this time with its Pfizer-backed experimental PD-L1 candidate avelumab set to be used alongside Transgene’s cancer vax TG4001. Tuesday, October 11, 2016 Specialty pharma Supernus has posted positive data from its childhood ADHD midstage test as it looks to start Phase III trials next year--but its shares ticked down as some decided to “sell the news” instead of buying into it. Wednesday, October 12, 2016 Daiichi Sankyo has penned its third cancer pact of the past two weeks. The latest agreement adds a preclinical lung cancer collaboration with Dana-Farber Cancer Institute to the Japanese drugmaker’s fast-growing list of oncology alliances. Tuesday, October 11, 2016 No currently available treatment can halt or delay the progression of Alzheimer’s disease, but Imperial College London researchers found that gene therapy may be able to prevent its onset altogether, at least in mice. Monday, October 10, 2016 Bristol-Myers Squibb and Bavarian Nordic are getting underway with their $1 billion Prostvac clinical partnership, kicking off a Phase II trial of Yervoy and Prostvac in early prostate cancer. Wednesday, October 12, 2016 Abbott struck companion diagnostic deals with two biotech companies to use its PCR testing to identify mutations in leukemia patients that would make them a good fit for therapy. | This week's sponsor is FierceBiotech. | | | FierceBiotech Presents:
A Half Day Executive Summit
Hosted at the Royal Society of Medicine, London
R&D Challenges: A UK Perspective
Cocktail Reception to follow
27 October, 2016
Register Now! |
| | | MediciNova has gained a coveted orphan drug tag for its experimental ALS med ibudilast. Release RNAi biotech RXi Pharmaceuticals Corporation is looking to buyout the I/O co MirImmune in a complex play. Statement Plymouth Meeting, PA-based biotech Inovio Pharmaceuticals has added two cancer docs and a plasmid manufacturing expert to its ranks. Release | |
|
Resources Presented by: DocuSign DocuSign’s eSignature solutions modernize healthcare and life science organizations by eliminating paper and antiquated signature processes while meeting compliance requirements and reducing costs and errors. Presented by: DocuSign The U.S. Department of Justice has collected upwards of $17 billion in settlements from the healthcare industry since 2009, including more than $2 billion from a single life sciences company. Presented by: DocuSign The patients who rely on your scientific leadership are expecting more. Sponsored By: Salesforce Life sciences companies, like many industries today, face new challenges across the board. Read More. Presented By: ISR Reports Make essential outsourced bioprocessing decisions by staying informed of industry outsourcing practices and contract manufacturer usage patterns with ISR’s Bioprocessing Services and Technologies Market Trends and Outsourcing Dynamics report. Presented By: ISR Reports ISR’s Biosimilars in the US Oncology Market (2nd Edition) report provides data and insights from 101 US-based, board-certified oncologists/hematologist oncologists as to their expectations, fears, and aspirations for biosimilars in oncology. Presented By: ISR Reports Pinpoint the information oncologists find most valuable and the best sales channels for delivering specific types of data/information. Presented by: Covance The role of health economic data has never been more important. Presented by: Covance Leading manufacturers increasingly employ stakeholder research early in development to better identify the needs of patients and providers. Presented By: ISR Reports ISR’s Bioprocessing Market Trends and Outsourcing Dynamics: 2016-2021 report provides an overview of the current market dynamics for bioprocessing as well as an outlook on what the marketplace will look like in five years. Presented By: ISR Reports ISR’s CRO Quality Benchmarking – Phase II/III Service Providers (8th Edition) report provides a Consumer Reports-style analysis of Phase II/III CRO service quality from hundreds of users who rated 44 Phase II/III CROs across 26 critical dimensions of quality. Presented by: Patheon Can you avoid a risky trial-and-error approach to find the right path for your poorly soluble molecule by utilizing a CDMO? Download this complimentary Whitepaper to learn more! Presented by: Biotech Primer This 3-part webinar series is specifically geared toward the non-science professional who needs to better understand industry terminology, science, techniques and issues. Sponsored by: Veeva Systems Gartner research on short- and long-term strategies for IDMP compliance. Cannabis-Based Therapies November 30–December 1, 2016 | San Francisco, CA Drug Development Boot CampTM 2016 November 16-17, 2016 | Boston, MA Clinical Diagnostics & Research November 2-3, 2016 PepTalk: The Protein Science Week January 9-13, 2017 | San Diego, CA FierceBiotech Executive Summit October 27, 2016 | London CBI’s 7th West Coast Compliance Congress November 9-10, 2016 | San Francisco, CA Master of Science in Bioinformatics at Northeastern University Fall 2016, Spring 2017 Courses Discover the Richness of Latin America November 29–30, 2016 | San Juan, Puerto Rico AdvaMed 2016: The MedTech Conference in Minneapolis October 17-19, 2016 | Minneapolis, MN | 